Science Explorer Back to mapMap
Discussion
Topic · Pathology and Forensic Medicine

Lymphoma Diagnosis and Treatment

Lymphoma Diagnosis and Treatment is a research topic within Pathology and Forensic Medicine. Science Explorer counts 66k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the classification, molecular profiling, genetic pathogenesis, and treatment strategies for various types of lymphoid neoplasms, including Hodgkin's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. It also explores the use of PET imaging, rituximab therapy, and gene expression profiling to predict survival and guide treatment decisions.

  • Lymphoma
  • Classification
  • Molecular Profiling
  • Rituximab
  • Genetic Pathogenesis
  • PET Imaging
  • Hodgkin's Lymphoma
  • B-Cell Receptor Signaling
  • Mantle Cell Lymphoma
  • Gene Expression Profiling
Research works
66k
fractional, since 1950
In the world top 10%
6.7k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+13%
the tick is no change
Largest producer
United States
38% of the 10 largest, 2022-now
Lymphoma Diagnosis and Treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Lymphoma Diagnosis and Treatment research?

By volume, the United States and China publish the most (3.7k and 2.2k works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.7k works
  2. 2 China 2.2k works
  3. 3 Japan 695 works
  4. 4 Italy 542 works
  5. 5 Germany 483 works
  6. 6 India 476 works
  7. 7 France 448 works
  8. 8 United Kingdom 372 works
  9. 9 Spain 359 works
  10. 10 Brazil 270 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 38.5%China: 23.3%Japan: 7.3%Italy: 5.7%6 others listed: 25.3%38%largest
United States3,662 · 38.5%China2,215 · 23.3%Japan695 · 7.3%Italy542 · 5.7%6 others listed2,409 · 25.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Lymphoma Diagnosis and Treatment research?

By volume in 2022-now, The University of Texas MD Anderson Cancer Center publishes the most Lymphoma Diagnosis and Treatment research, followed by Mayo Clinic and Harvard University.

By volume, 2022-now

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 187 works
  2. 2 Mayo ClinicUnited States 156 works
  3. 3 Harvard UniversityUnited States 147 works
  4. 4 Memorial Sloan Kettering Cancer CenterUnited States 105 works
  5. 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 105 works
  6. 6 Sun Yat-sen UniversityChina 103 works
  7. 7 Shanghai Jiao Tong UniversityChina 93 works
  8. 8 Peking UniversityChina 93 works
  9. 9 Sichuan UniversityChina 79 works
  10. 10 Nanjing Medical UniversityChina 78 works

Who are the leading researchers in Lymphoma Diagnosis and Treatment?

The most-cited researchers publishing on Lymphoma Diagnosis and Treatment include David Moher, Ahmedin Jemal and Freddie Bray.

  1. 1 David Moher Canada 898k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Freddie Bray France 550k citations
  4. 4 Eric S. Lander United States 524k citations
  5. 5 Jacques Ferlay France 486k citations
  6. 6 Mark J. Daly United States 403k citations
  7. 7 Stacey L. Gabriel United States 402k citations
  8. 8 Robert John Tibshirani United States 396k citations
  9. 9 Guido Kroemer France 386k citations
  10. 10 Bert Vogelstein United States 373k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Lymphoma Diagnosis and Treatment?

The most cited paper in Lymphoma Diagnosis and Treatment is "Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics" (Yoshinobu Kanda, 2012), with 19,316 citations. Next come "Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus" (11,602) and "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling" (10,021).

Most cited papers
#PaperReleasedCitations
1 Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics Yoshinobu Kanda · Bone Marrow Transplantation Open access 3 Dec 2012 19,316
2 Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus Marc C. Hochberg · Arthritis & Rheumatism Sep 1997 11,602
3 Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Ash A. Alizadeh et al. · Nature Feb 2000 10,021
4 Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer Open access 1977 8,414
5 The 2016 revision of the World Health Organization classification of lymphoid neoplasms Steven H. Swerdlow, Elı́as Campo, Stefano Aldo Pileri et al. · Blood Open access 15 Mar 2016 7,935
All 100 most cited papers, with filters and sorting

Where is Lymphoma Diagnosis and Treatment research done?

The largest centres of Lymphoma Diagnosis and Treatment research in 2022-now are Beijing (China), New York (United States), Houston (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bellinzona, Duarte and Lancaster.

Largest cities, 2022-now

  1. 1 BeijingChina 352 works
  2. 2 New YorkUnited States 265 works
  3. 3 HoustonUnited States 236 works
  4. 4 ShanghaiChina 206 works
  5. 5 ParisFrance 161 works
  6. 6 GuangzhouChina 160 works
  7. 7 TokyoJapan 159 works
  8. 8 BostonUnited States 136 works
  9. 9 SeoulSouth Korea 130 works
  10. 10 LondonUnited Kingdom 125 works

Where it is the local speciality

  1. BellinzonaCH · 20.4 works52×
  2. DuarteUS · 35.5 works51×
  3. LancasterUS · 35.8 works36×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Lymphoma Diagnosis and Treatment than the world average.

See Lymphoma Diagnosis and Treatment on the map

Where is the best place to study Lymphoma Diagnosis and Treatment?

Among universities, judged by research, Kettering University, Harvard University and Sun Yat-sen University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.27%fractional works in this field (log) →share of work in the world top 10% →Kettering UniversityUniversity of MiamiHarvard UniversitySun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Kettering UniversityUnited States 67.145.3%46.5×18 -
2Harvard UniversityUnited States 66.818.9%4.2×147 -0.8%
3Sun Yat-sen UniversityChina 57.914.7%4.5×103 +37.1%
4University of MiamiUnited States 56.626.1%6.7×45 +6.0%
5Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 56.29.8%9.1×105 +52.8%
6Università della Svizzera italianaSwitzerland 54.819.7%20.1×18 +7.5%
7Cornell UniversityUnited States 54.119.3%4.6×66 -8.4%
8Shanghai Jiao Tong UniversityChina 54.013.3%3.0×93 +74.5%
9Peking UniversityChina 53.59.4%4.2×93 +31.2%
10University of PennsylvaniaUnited States 53.416.2%4.6×53 +13.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Lymphoma Diagnosis and Treatment, country by country

Is Lymphoma Diagnosis and Treatment research growing?

Output in 2022-2025 was 13% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Lymphoma Diagnosis and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Lymphoma Diagnosis and Treatment as a percentage of every work published that year, 0.050% in 2024.

still counting0.050%0.10%Lymphoma Diagnosis and Treatment0.055% in 202519801990200020102020

Fractional works of Lymphoma Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Lymphoma Diagnosis and Treatment10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Lymphoma Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.